We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
신규 편입 · 포트폴리오 비중 0.00%
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $6.83 · 6 analysts
Stored first · Google News · Yahoo Finance (English)
BMEA ANNOUNCEMENT: If You Have Suffered Losses in Biomea Fusion, - GuruFocus
BMEA ANNOUNCEMENT: If You Have Suffered Losses in Biomea Fusion, GuruFocus
Biomea Fusion presents Phase II data on icovamenib in type 1 diabetes at ADA meeting - Traders Union
Biomea Fusion presents Phase II data on icovamenib in type 1 diabetes at ADA meeting Traders Union
Biomea Fusion Inc. (BMEA) Q1 2026 Earnings: Narrower-than-expected loss highlights cost management - Return On Equity - dars.gov.et
Biomea Fusion Inc. (BMEA) Q1 2026 Earnings: Narrower-than-expected loss highlights cost management - Return On Equity dars.gov.et
Insiders Buying Biomea Fusion Might Wish They Invested More, Stock Gains 12% - simplywall.st
Insiders Buying Biomea Fusion Might Wish They Invested More, Stock Gains 12% simplywall.st
Enterprise value to EBITDA forward of Biomea Fusion, Inc. – NASDAQ:BMEA - TradingView
Enterprise value to EBITDA forward of Biomea Fusion, Inc. – NASDAQ:BMEA TradingView
Biomea Fusion Inc Actuals & Estimates (NASDAQ:BMEA) - TradingView
Biomea Fusion Inc Actuals & Estimates (NASDAQ:BMEA) TradingView
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 04. | After market close (AMC) | $-0.21 | — | — | $0 | — | Scheduled |
| FY2022 Q3 | 2022. 09. 30. | Time TBD | — | $-1.21 | — | — | $1.24B | Reported |
| FY2022 Q2 | 2022. 06. 30. | Time TBD | — | — | — | — | $1.07B | Reported |
| FY2022 Q1 | 2022. 03. 31. | Time TBD | — | — | — | — | $1.07B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 05. | Citizens | — | Initiate coverage | — → Market Outperform | — | Citizens: Market Outperform |
| 2026. 04. 28. | D. Boral Capital | — | Maintain | Buy → Buy | — | D. Boral Capital: Buy |
| 2026. 04. 08. | D. Boral Capital | — | Maintain | Buy → Buy | — | D. Boral Capital: Buy |
| 2026. 03. 28. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2026. 03. 26. | D. Boral Capital | — | Maintain | Buy → Buy | — | D. Boral Capital: Buy |
| 2026. 01. 13. | D. Boral Capital | — | Maintain | Buy → Buy | — | D. Boral Capital: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 388,696 | $594.71K | 0.00% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 423,469 | $525.1K | 0.00% | — | New position |
| 3 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 17,261 | $21.4K | 0.00% | — | New position |